These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17656252)

  • 1. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors.
    Patel AS; Murphy KM; Hawkins AL; Cohen JS; Long PP; Perlman EJ; Griffin CA
    Cancer Genet Cytogenet; 2007 Jul; 176(2):107-14. PubMed ID: 17656252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
    Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).
    Chikatsu N; Kojima H; Suzukawa K; Shinagawa A; Nagasawa T; Ozawa H; Yamashita Y; Mori N
    Mod Pathol; 2003 Aug; 16(8):828-32. PubMed ID: 12920229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
    Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia.
    Lim JH; Jang S; Park CJ; Cho YU; Lee JH; Lee KH; Lee JO; Shin JY; Kim JI; Huh J; Seo EJ
    Cancer Genet; 2014; 207(1-2):40-5. PubMed ID: 24613277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).
    Argani P; Lui MY; Couturier J; Bouvier R; Fournet JC; Ladanyi M
    Oncogene; 2003 Aug; 22(34):5374-8. PubMed ID: 12917640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
    Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
    Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
    Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
    Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.
    Bridge JA; Kanamori M; Ma Z; Pickering D; Hill DA; Lydiatt W; Lui MY; Colleoni GW; Antonescu CR; Ladanyi M; Morris SW
    Am J Pathol; 2001 Aug; 159(2):411-5. PubMed ID: 11485898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma.
    Lamant L; Gascoyne RD; Duplantier MM; Armstrong F; Raghab A; Chhanabhai M; Rajcan-Separovic E; Raghab J; Delsol G; Espinos E
    Genes Chromosomes Cancer; 2003 Aug; 37(4):427-32. PubMed ID: 12800156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
    Griffin CA; Hawkins AL; Dvorak C; Henkle C; Ellingham T; Perlman EJ
    Cancer Res; 1999 Jun; 59(12):2776-80. PubMed ID: 10383129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
    Chen ST; Lee JC
    Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crizotinib resistance in acute myeloid leukemia with inv(2)(p23q13)/RAN binding protein 2 (RANBP2) anaplastic lymphoma kinase (ALK) fusion and monosomy 7.
    Takeoka K; Okumura A; Maesako Y; Akasaka T; Ohno H
    Cancer Genet; 2015 Mar; 208(3):85-90. PubMed ID: 25766836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification.
    Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y
    Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
    Coffin CM; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.